ARFRP1 (ADP-ribosylation factor related protein 1) is a member of the ARF family of GTP-binding proteins, which are critical components in the regulation of vesicle trafficking and membrane transport within eukaryotic cells. The ARFRP1 protein is encoded by the ARFRP1 gene and is predominantly associated with the trans-Golgi network (TGN), where it plays a significant role in the sorting and movement of proteins from the Golgi apparatus to their appropriate destination.As a GTPase, ARFRP1 can switch between an active GTP-bound state and an inactive GDP-bound state. This switching is regulated by guanine nucleotide exchange factors (GEFs) that promote the exchange of GDP for GTP, and GTPase-activating proteins (GAPs) that stimulate the hydrolysis of GTP back to GDP. In its active form, ARFRP1 can interact with various effector molecules to orchestrate vesicle budding, transport, and fusion processes.
One of the critical functions of ARFRP1 is in maintaining the structural integrity and functionality of the Golgi apparatus. It has been implicated in the recruitment of coat proteins that are necessary for vesicle formation, as well as in the regulation of lipid metabolism and the maintenance of lipid composition in Golgi membranes. This is essential for the proper sorting and processing of lipids and proteins that are transported through the secretory pathway.Disruption of ARFRP1 function can lead to various cellular dysfunctions, including defects in protein trafficking and lipid metabolism, and is associated with developmental abnormalities and diseases. For example, loss of ARFRP1 activity can result in mislocalization of enzymes and receptors, leading to metabolic imbalances and contributing to disease pathogenesis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels, which can indirectly enhance ARFRP1 by promoting lipid modifications that affect ARFRP1's membrane association. | ||||||
L-α-Lecithin, Egg Yolk, Highly Purified | 8002-43-5 | sc-203096 | 250 mg | $135.00 | ||
Phosphatidic acid can act as a lipid messenger that influences membrane curvature, potentially facilitating ARFRP1's role in vesicle formation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C which can phosphorylate proteins involved in vesicular trafficking, indirectly promoting ARFRP1's function. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin increases intracellular calcium levels, which can modulate vesicle fusion events where ARFRP1 is active. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
As a cAMP analog, 6-Bnz-cAMP enhances PKA activity, potentially affecting ARFRP1's role in vesicular trafficking through phosphorylation events. | ||||||
NOC-18 | 146724-94-9 | sc-202247 sc-202247A sc-202247B sc-202247C | 10 mg 50 mg 100 mg 500 mg | $51.00 $184.00 $305.00 $1122.00 | 18 | |
Nitric oxide can modulate vesicular trafficking via S-nitrosylation of cytosolic components, indirectly affecting ARFRP1 activity. | ||||||
Crenolanib | 670220-88-9 | sc-364470 sc-364470A | 5 mg 10 mg | $612.00 $1020.00 | ||
GTPγS is a non-hydrolyzable GTP analog that may stabilize GTP-bound ARFRP1, enhancing its GTPase activity. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
LPA acts as a signaling lipid that can influence membrane dynamics, potentially supporting ARFRP1's role in vesicular trafficking. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin polymerization, which might enhance ARFRP1's function in vesicle formation and trafficking. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that can modulate vesicular trafficking pathways, potentially augmenting ARFRP1's activity in these processes. | ||||||